You searched for Antibody candidate - Page 32 of 69

News and Trends 31 Oct 2016

Shooting for the Moon: German Biotech Acquired for a Record €1.3B

…in Germany. Astellas will pay €442M upfront and is offering up to an extra €860M pending the successful development of Ganymed’s pipeline lead candidate, IMAB362. The therapeutic antibody has orphan…

October 31, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

rheumatoid arthritis anti il 6r ablynx abbvie

News and Trends 9 Aug 2016

Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie

Ablynx has disclosed ‘compelling’ results for its Phase IIb trial in rheumatoid arthritis. But it might have a hard time compelling AbbVie to pay €68M to continue the candidate’s development,…

August 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 26 Aug 2016

US Money Magnet get hands on UK Bispecific Antibodies for Neurodegenerative Disease

F-star’s “plug-and-play” technology can turn any existing antibody into a full-size bispecific antibody. Denali has recognized its potential use for drug delivery to the CNS and inked a deal with…

August 26, 2016 - 2 minutesmins - By Evelyn Warner

In Depth 15 May 2024

Drugs for IgA nephropathy on the rise in the clinic

…the kidneys against placebo in a phase 3 trial. The study is set to end next year. Moreover, Boston-based Alexion Pharmaceuticals’ monoclonal antibody ALXN1210, also known as ravulizumab is currently…

May 15, 2024 - 9 minutesmins - By Roohi Mariam Peter

ablynx llama antigody nanobody rsv infant

News and Trends 3 May 2016

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Ablynx has gotten positive results for its candidate (ALX-0171) in Phase I/IIa trial for infants infected with a life-threatening virus – respiratory syncytial virus (RSV). Located near Ghent (Belgium), Ablynx…

May 3, 2016 - 2 minutesmins - By Denise Neves Gameiro

Philogen cancer immunotherapy antibody pharma t cell

News and Trends 25 Jan 2019

Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma

The Swiss-Italian company Philogen has announced three different partnerships with Novartis, Celgene, and Janssen to develop new forms of immunotherapy and small molecule drugs. Philogen develops immunocytokines, which are antibodies…

January 25, 2019 - 2 minutesmins - By Jonathan Smith

radiopharmaceutical treatments precirix jeito

News and Trends 17 Mar 2022

€80M Series B Establishes European Champion in Radiopharmaceuticals

…cancer-seeking component is a fragment of an antibody found in animals from the camelid family, which includes llamas and camels. These antibody fragments bind to their targets as strongly as…

March 17, 2022 - 4 minutesmins - By Jonathan Smith

Interview 2 Sep 2020

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

…proteins interact with each other, forming aggregates. The team at Axon was able to identify it by developing an antibody that blocked the interaction between tau proteins by targeting that…

September 2, 2020 - 8 minutesmins - By Farhan Mitha

Best in Biotech 9 May 2023

5 cancers that immunotherapy can cure

…for multiple myeloma.The first three approved immunotherapies for multiple myeloma were antibody-based immunotherapies, all approved for subsets of patients with advanced multiple myeloma: daratumumab (Darzalex) – a monoclonal antibody targeting…

May 9, 2023 - 7 minutesmins - By Willow Shah-Neville

News and Trends 20 Jul 2017

Update: Danish Psoriasis Drug Gets EU Approval Despite Suicide Links

…a positive opinion for Leo Pharma’s psoriasis drug brodalumab, even though the drug has been associated with suicidal behavior. Brodalumab, a fully human antibody targeting the IL-17 receptor, is part…

July 20, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 19 Feb 2018

Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?

Two clinical studies have demonstrated the capacity of Novartis’ monoclonal antibody to treat both plaque and scalp psoriasis and improve patient quality of life. Not only is Novartis leading the…

February 19, 2018 - 3 minutesmins - By Alex Dale

Interview 2 Jan 2017

The Story behind one of the Most Successful Danish Biotech Entrepreneurs

…became co-founders of Symphogen. I was in my 30s and we believed everything was possible, including building the next big antibody company; an idea inspired by Genmab, now a €10Bn…

January 2, 2017 - 6 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Shooting for the Moon: German Biotech Acquired for a Record €1.3B

Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie

US Money Magnet get hands on UK Bispecific Antibodies for Neurodegenerative Disease

Drugs for IgA nephropathy on the rise in the clinic

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma

€80M Series B Establishes European Champion in Radiopharmaceuticals

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

5 cancers that immunotherapy can cure

Update: Danish Psoriasis Drug Gets EU Approval Despite Suicide Links

Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?

The Story behind one of the Most Successful Danish Biotech Entrepreneurs

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!